- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT05244356
Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation (CONVINCE)
Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Selangor
-
Shah Alam, Selangor, Malajsie, 40170
- Institute for Clinical Research, National Institutes of Health, Malaysia
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Willing and able to give informed consent for participation in the trial
- Malaysian nationality.
- Can understand either the English or Malay language.
- Aged 18 years or above
Exclusion Criteria:
- Received at least one COVID-19 vaccination dose
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Descriptive Norm (70%)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Descriptive Norm
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Healthcare worker (HCW) recommendation
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Negative attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Positive attribute framing
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Risky choice framing (Safety)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Risky choice framing (Side effects)
Intervention in the form of a message likened to a social media post. Composed of 3 parts:
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Control message
Control message containing only rally slogan: "It's safe and effective!"
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + Descriptive Norm
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + HCW recommendation
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + Negative attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + Positive attribute framing
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
|
Experimentální: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)
Participants received 2 messages which were exposed one at a time.
Sequence of message appearing randomly rotated.
|
Participants exposed to a health message and requested to read it completely.
Subsequently requested to answer post intervention questions that form basis for outcome measures.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population.
Časové okno: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale.
Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to healthy adults.
Časové okno: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to elderly.
Časové okno: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Change in intent to recommend the COVID-19 vaccine to people with existing health conditions.
Časové okno: Immediately before and after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately before and after message exposure during questionnaire administration.
|
|
Intent to share message on social media platform.
Časové okno: Immediately after message exposure during questionnaire administration.
|
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Moderators of vaccination intent.
Časové okno: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a series of questions answered through a 5 point ordinal scale.
Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
|
Immediately after message exposure during questionnaire administration.
|
|
Reliability of various information sources about COVID-19.
Časové okno: Immediately after message exposure during questionnaire administration.
|
Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale.
Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".
|
Immediately after message exposure during questionnaire administration.
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- NMRR-21-26-58107
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .